Tell Us What Happened
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form.
Molecular Mechanism Research Services
Validate molecular targets, elucidate signaling cascades, and quantify gene expression changes in a high-throughput in vivo vertebrate model. Our zebrafish platform enables rapid, cost-effective assessment of inflammation, muscle health, and disease pathways with direct translational relevance.
Request a consultationA vertebrate model that bridges in vitro and mammalian systems
Zebrafish (Danio rerio) have emerged as a powerful vertebrate model for studying gene expression dynamics and signaling pathway activation in a whole-organism context. Their high fecundity, external development, and optical transparency allow real-time imaging of fluorescent reporters, while conserved genetic and physiological pathways ensure translational relevance to human biology. This combination makes zebrafish an ideal platform for target validation, compound screening, and mechanistic elucidation in early-stage drug discovery.
Our service integrates multiple gene expression analysis techniques, including quantitative PCR (qPCR), whole-mount in situ hybridization (WISH), and reporter transgenic lines, to provide comprehensive spatial and temporal expression data. We also support signaling cascade profiling through phospho-specific antibodies and pathway-specific reporter constructs. Whether you are investigating inflammation-induced muscle atrophy, metabolic stress, or developmental signaling, our zebrafish models deliver reproducible, scalable data to guide your preclinical decisions.
By leveraging the zebrafish model, you can reduce the number of rodent studies needed, accelerate screening timelines, and obtain early in vivo evidence of target engagement and pathway modulation. All experiments are performed under defined conditions with appropriate controls, and data are provided with detailed documentation for reporting and publication.
Conserved signaling pathways Key signaling cascades—including NF-κB, Wnt, Notch, and TGF-β—are highly conserved between zebrafish and humans, enabling direct translation of findings to mammalian systems.
Three pillars that set our platform apart
Unlike cell-based assays, zebrafish provide a complete physiological environment with intact cell–cell interactions, tissue architecture, and systemic signaling. This reduces false positives and improves predictive value for subsequent mammalian studies.
With hundreds of embryos per mating and rapid development, you can screen multiple conditions or time points in parallel. This accelerates hit-to-lead progression without sacrificing vertebrate relevance.
Combine qPCR, in situ hybridization, and transgenic reporter lines with morphological and behavioral endpoints. This integrated approach reveals both molecular and functional consequences of target modulation.
How we quantify and visualize molecular events in vivo
Stable transgenic strains carrying fluorescent reporters under the control of pathway-specific promoters (e.g., NF-κB, Wnt) enable real-time, non-invasive monitoring of signaling activation in live embryos.
Morpholino antisense oligos or CRISPR/Cas9-mediated mutagenesis are used to modulate gene expression, allowing functional validation of candidate genes and assessment of downstream signaling effects.
High-sensitivity qPCR from whole embryos or dissected tissues provides precise quantification of target gene transcript levels, normalized to housekeeping genes and calibrated with standard curves.
Spatial expression patterns of mRNAs are visualized using digoxigenin-labeled riboprobes, revealing tissue-specific and developmental stage-specific expression dynamics.
Small-molecule inhibitors targeting key signaling nodes (e.g., IKK, GSK-3β) are used to dissect pathway involvement and to confirm specificity of observed effects.
Models and readouts for key therapeutic areas
LPS-induced or chemical irritant models for studying cytokine expression, NF-κB activation, and immune cell infiltration.
Dexamethasone-induced atrophy or genetic models to assess MuRF1, MAFbx, and IGF-1 signaling in muscle health.
High-fat diet or chemical-induced obesity models for measuring insulin signaling, lipid metabolism genes, and oxidative stress markers.
MPTP or rotenone models for Parkinson’s, Aβ aggregates for Alzheimer’s; quantify neurotrophin signaling and apoptosis markers.
Assess cardiac gene expression (nppa, myh6) and calcium signaling in heart failure or arrhythmia models.
Transgenic tumor models (e.g., MYC-driven) or xenografts for evaluating oncogene expression, angiogenesis, and metastasis markers.
Screen compounds for teratogenicity by quantifying expression of developmental genes (sox2, pax2, shh) and stress pathway markers.
Chemical-induced liver injury models for analyzing CYP450 expression, Nrf2 signaling, and inflammatory cytokines.
Evaluate the trade-offs for your research question
| Feature | Zebrafish | Mouse | Cell | Organoid |
|---|---|---|---|---|
| In vivo whole-organism context | Yes | Yes | No | Partial |
| Spatial expression data (in situ) | Routine | Routine | Limited | Possible |
| High-throughput (N > 96 per run) | Yes | No | Yes | No |
| Cost per data point | Low | High | Low | Moderate |
| Genetic manipulation speed | Fast (morpholino/CRISPR) | Slow (months) | Fast | Moderate |
| Real-time live imaging | Yes | Difficult | Yes | Limited |
| Translational relevance to human | High (conserved pathways) | Very high | Moderate | Moderate |
| Ethical burden | Low (early non-protected stages) | High | None | Low |
From consultation to data delivery in three phases
We discuss your gene of interest, signaling pathway, and desired endpoints. Options include morpholino knockdown, CRISPR/Cas9 knockout, or transgenic reporter line crossing. We also design riboprobes and qPCR primers tailored to the project.
Embryos are collected, staged, and treated according to the protocol. Whole-mount in situ hybridization (WISH), RNA extraction for qPCR, or live imaging of transgenic reporters is performed. All samples are processed with technical replicates and appropriate controls.
Raw data (expression levels, imaging stacks) are analyzed using validated pipelines. We provide fold-change values, statistical significance, spatial expression maps, and a comprehensive report with methods and results for publication or internal decision-making.
From raw sequencing reads to interpretable gene expression profiles
How researchers use our zebrafish gene expression services
A client screened a polyphenol-rich extract for anti-inflammatory effects in a zebrafish LPS-induced inflammation model. qPCR analysis of tnfα, il1β, and nfκb expression showed dose-dependent suppression, supporting further preclinical development.
Using a dexamethasone-induced atrophy model, we quantified MuRF1 and MAFbx expression by qPCR and confirmed activation of the ubiquitin-proteasome pathway. Co-treatment with a candidate compound rescued expression levels, indicating therapeutic potential.
CRISPR/Cas9 knockout of a candidate gene was performed, followed by whole-mount in situ hybridization for known target genes. Loss of expression of sox2 and pax2a in the forebrain confirmed a role in neural patterning.
A transgenic Wnt reporter line was used to monitor β-catenin signaling in vivo. After treatment with a small-molecule inhibitor, we observed dose-dependent reduction of fluorescence, validated by qPCR of Wnt target genes (axin2, lef1).
Examples of common project scopes and requirements
| Project Type | Material Required | Amount | Turnaround |
|---|---|---|---|
| qPCR gene expression analysis (target panel) | Total RNA from zebrafish embryos/tissue | ≥ 1 μg per sample, 3–6 biological replicates | Varies by project |
| Whole-mount in situ hybridization (single gene) | Fixed embryos (staged and dechorionated) | ≥ 20 embryos per condition | Varies by project |
| Transgenic reporter imaging (live) | Transgenic line embryos (provided or generated) | ≥ 30 embryos per group | Varies by project |
| CRISPR/Cas9 knockout + expression analysis | Guide RNA/Cas9 or morpholino (client-supplied or designed) | 100–200 embryos per injection condition | Varies by project |
| RNA-seq transcriptome profiling | Total RNA, DNase-treated | ≥ 500 ng per sample, 3 replicates per condition | Varies by project |
| Single-cell RNA-seq (scRNA-seq) | Dissociated cells from zebrafish embryos/larvae | ≥ 10,000 cells per sample, 2–3 conditions | Varies by project |
Full project deliverables to support your research
Common inquiries about our zebrafish gene expression services
How do you ensure that the zebrafish model is relevant to human disease pathways?
Zebrafish share >70% of disease-associated genes with humans, and key signaling pathways (NF-κB, Wnt, Notch, etc.) are highly conserved. We validate human gene orthologs using databases like ZFIN and cite published literature confirming pathway conservation.
Can you analyze gene expression in specific tissues or cell types?
Yes. We can dissect tissues (e.g., brain, liver, muscle) from larvae for tissue-specific qPCR. For cell-type resolution, we offer single-cell RNA sequencing or in situ hybridization with cell-type markers.
What controls are used in your experiments?
Each experiment includes negative controls (untreated/uninjected embryos), positive controls (known pathway activators/inhibitors), and housekeeping gene normalization for qPCR. For morpholino/CRISPR, we include standard control oligos and rescue experiments where feasible.
Do you provide custom transgenic reporter lines?
Yes, we can generate stable transgenic lines expressing fluorescent reporters under your promoter of interest. This service is available upon request and requires additional design and validation time.
What are the limitations of the zebrafish model for gene expression studies?
Zebrafish lack some mammalian-specific organ features (e.g., lungs, mammary glands). For certain signaling pathways, cross-species validation may be needed. However, for most core pathways, zebrafish provide excellent predictive value.
Tell Us What Happened
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form.